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Abstract 
Background: Nanoparticles (NPs) are receiving increasing interest in biomedical research owing to their compa-
rable size with biomolecules, novel properties and easy surface engineering for targeted therapy, drug delivery and 
selective treatment making them a better substituent against traditional therapeutic agents. ZnO NPs, despite other 
applications, also show selective anticancer property which makes it good option over other metal oxide NPs. ZnO 
NPs were synthesized by chemical precipitation technique, and then surface modified using Triton X-100. Compara-
tive study of cytotoxicity of these modified and unmodified NPs on breast cancer cell line (MDA-MB-231) and normal 
cell line (NIH 3T3) were carried out.
Results: ZnO NPsof average size 18.67 ± 2.2 nm and Triton-X modified ZnO NPs of size 13.45 ± 1.42 nm were synthe-
sized and successful characterization of synthesized NPs was done by Fourier transform infrared spectroscopy (FT-IR), 
X-Ray diffraction (XRD), transmission electron microscopy (TEM) analysis. Surface modification of NPs was proved 
by FT-IR analysis whereas structure and size by XRD analysis. Morphological analysis was done by TEM. Cell viability 
assay showed concentration dependent cytotoxicity of ZnO NPs in breast cancer cell line (MDA-MB-231) whereas no 
positive correlation was found between cytotoxicity and increasing concentration of stress in normal cell line (NIH 
3T3) within given concentration range. Half maximum effective concentration (EC50) value for ZnO NPs was found to 
be 38.44 µg/ml and that of modified ZnO NPs to be 55.24 µg/ml for MDA-MB-231. Crystal violet (CV) staining image 
showed reduction in number of viable cells in NPs treated cell lines further supporting this result. DNA fragmentation 
assay showed fragmented bands indicating that the mechanism of cytotoxicity is through apoptosis.
Conclusions: Although use of surfactant decreases particle size, toxicity of modified ZnO NPs were still less than 
unmodified NPs on MDA-MB-231 contributed by biocompatible surface coating. Both samples show significantly 
less toxicity towards NIH 3T3 in concentration independent manner. But use of Triton-X, a biocompatible polymer, 
enhances this preferentiality effect. Since therapeutic significance should be analyzed through its comparative effect 
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Background
Anticancer therapies relying on chemical, biological 
and natural products are not showing promising results 
because of their similar toxic effect on both normal pro-
liferating cells and cancerous cell [1]. Hence, search for 
efficient and selective treatment for cancer has been a 
keen area of interest for most researchers which lead to 
selective targeting, delivery vehicles and selective agents 
engineering. The nanoscale magnitude and high surface 
area to volume ratio of NPs allow them to rework their 
characteristic properties permitting them to interact 
with biomolecules in a distinct way [2]. This property has 
increased the possibility of surface engineering according 
to need in cancer therapy, cell imaging, bio-sensing and 
drug delivery. Use of surfactant will reduce particle size 
but also alter the surface property of NPs [3]. Non-ionic 
polymers like TritonX, Tween 20, PEG, etc. have been 
widely used to make biocompatible surfaces for enhanc-
ing activity in biological environment in both delivery 
and therapeutic agents [4]. With extensive studies of 
anticancer activity of various metal oxide NPs, ZnO NPs, 
with above facts and findings, this research aims to study 
the effect of surface altered ZnO NPs by TritonX-100 on 
preferential cytotoxicity in cancer cell invitro by compar-




Zinc acetate (Zn(CH3COO)2) is soluble in methanol 
giving colorless solution. When methanolic solution 
of NaOH, a strong base is added dropwise to colorless 
ZnAc solution, white precipitate of Zn(OH)2 is formed. 
Upon adding excess concentrated NaOH, Zn(OH)2 dis-
solve to give Zincate (Zn(OH)42−) ion at stoichiomet-
ric ratio. Under vigorous stirring considerable extent of 
Zincate dissociates into Zn++ and OH− ions which upon 
reaching critical concentration forms, ZnO precipitates. 
Because of higher solubility of Zn(OH)2 as Zincate than 
ZnO in such condition, the reaction is favoured towards 
formation of ZnO [11].
on both normal and cancer cells, possible application of biocompatible polymer modified nanoparticles as therapeu-
tic agent holds better promise.
Keywords: ZnO nanoparticles, Surface modification, Triton X, Cytotoxicity
despite its other explicit applications on cosmetic, nano-
fabric and electronics [5], also shows selective killing of 
cancerous cell [6]. Although effect of surfactant on size 
and morphology of ZnO NPs is well characterized [7] and 
researches are also focused on explaining possible mech-
anism on preferential cytotoxicity [8, 9], study on signifi-
cance of surfactant altered modification of these NPs on 
change in cytotoxicity of cancer and normal cells lines 
from unaltered one is still lacking. TritonX-100 being 
non-ionic biocompatible surfactants consisting both 
hydrophilic polyethylene oxide chain and hydrophobic 
aromatic group, has excellent detergent property, wetting 




Zn(OH)2 + excess NaOH
Methanol/Vigorous Stirring
−−−−−−−−−−−−−−−−−−→ 2Na+ + Zn(OH)2−4
Zn(OH)2−4
Vigorous Stirring
−−−−−−−−−−−−−−−−−−→Zn2+ + 2OH−ZnO + H2O
 Subequent washing by distilled water removes excess 
base and sodium salts from the precipitate. Use of sur-
factant generally reduce particle size by interacting with 
formed nucleus and hindering other nucleus to come 
nearby during particle growth phase as shown in Fig.  1 
as a hypothetical model in which bulkier hydrophobic 
group of TritonX-100 will restrict the free collision of 
ZnO nucleus during particle growth [3].
Structural analysis
As it can be observed from Fig. 2, ZnO NPs (modified 
ZnO NPs) show sharp diffraction peaks correspond-
ing to hkl values of 100, 002, 101 and 110 at 2θ values 
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of 31.765 (31.693), 34.391 (34.308), 36.195 (36.112) 
and 56.606 (56.401) respectively pointing out to crys-
talline nature. Average particle size was obtained as 
18.67 ± 2.2 nm for ZnO NPs and 13.45 ± 1.42 nm for 
modified ZnO NPs using Scherrer’s equation. Relative 
intensities for modified ZnO NPs are less than that of 
unmodified ZnO NPs which could be due to coating 
of non-crystalline TritonX. Corresponding miller indi-
ces obtained from Powder X software indicate crystal-
line planes of polygonal Wurtzite structure of ZnO(A) 
[12]. The decrease in particle size in modified ZnO 
could be due to possible coating during synthesis pro-
cess where exposed bulky groups provide steric hin-
drances for nucleus agglomeration. Since particle size 
also depends on calcination period and time [13, 14], 
use of same parameters for both samples verify that the 
formation of reduced grain size is contributed by use of 
surfactant.
For morphological characterization of NPs, TEM 
images as in Figs.  3 and 4 were obtained which shows 
clear distinction of particle size reduction in case of sur-
factant used. TEM micrograph of ZnO in Fig.  3 shows 
clear polygonal structures whereas in case of modified 
ZnO in Fig.  4, quasi-spherical particles were seen. This 
is consistent with our result from XRD which shows 
less crystallinity of modified ZnO than unmodified one. 
Average particle size distribution of ZnO from TEM his-
togram was on 15–20 nm and for modified ZnO was on 
10–15  nm which was also consistent with XRD results. 
Polygonal shaped morphology was in accordance with 
crystalline Wurtzite structure of ZnO [15].
Fig. 1 A hypothetical model of surfactant interaction with ZnO nucleus during particle growth
Fig. 2 XRD peaks of ZnO (a) and modified ZnO (b) showing peaks 
at 2θ values from 5° to 80° with corresponding values showing miller 
indices (hkl values)
Page 4 of 10KC et al. Chemistry Central Journal  (2016) 10:16 
FT-IR analysis in Fig. 5 showed a series of absorption 
peaks. In case of zinc acetate dihydrateprecursor, broad 
peak was seen around 3000  cm−1 which was because 
of bonded −OH group. Peaks at 1400–1600  cm−1 were 
due to symmetrical and asymmetrical stretching of car-
boxyl (−COO) group. Peak at 400–500  cm−1 suggest 
divalent metal oxide bond which verified ZnO formation 
[16]. Comparing the precursor and ZnO powder, a sig-
nificant reduction in peak intensities at 1400–1600 cm−1 
was observed. This suggests significant decrease in car-
boxyl group in the synthesized compound. Hydroxide 
(−OH) peak at 3000–3500  cm−1 range was also com-
pletely absent. No impurities peaks were observed in syn-
thesized particles. In modified ZnO, characteristic peak 
of divalent metal oxide can be observed in accordance 
with unmodified ZnO with additional peaks similar to 
TritonX-100 which strongly suggests modification of syn-
thesized NPs.
Cytotoxicity study
Both ZnO and surface modified ZnO shows preferential 
cytotoxicity
Result of MTT assay was used to determine percentage 
cell death with respect to control (untreated cells) as a 
function of absorbance of dissolved formazan produced 
from conversion of MTT dye by the action of mitochon-
drial dehydrogenase enzyme [17]. Figure  6 shows both 
modified and unmodified ZnO NPs show preferential 
cytotoxicity against MDA-MB-231 compared to NIH 
3T3. Two factor ANOVA with replication was performed 
at α = 0.05 to analyze variance in effectiveness of concen-
tration gradient of NPs on two cell lines. Results shows 
p value for interaction was less than 0.05 for both ZnO 
and modified ZnO that reject null hypothesis of equal 
variance between effects on MDA-MB-231 and NIH 
3T3 which justify that effectiveness of concentration 
gradient of both NPs is different for these two cell lines. 
Fig. 3 TEM images of ZnO at (a) 50 nm (b) 100 nm scale with histogram showing particle size distribution
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This differential cytotoxicity has often been described as 
selectivity of nanoparticles [18].
Cytotoxicity of NPs also depends on surface characteristic, 
not only on size
Cytotoxic effect of NPs on MDA-MB-231 was found to 
be concentration dependent as shown in Fig. 7 with Adj. 
R2 of 0.97. The EC50 value of ZnO NPs for MDA-MB-
231was found to be 38.44 µg/ml whereas that of modified 
ZnO NPs was found to be 55.24 µg/ml. While comparing 
variance of results obtained for ZnO NPs and modified 
ZnO NPs fitted under the same function using F-test, 
p value was obtained less than 0.05 which signifies that 
the effect of TritonX-100 on cytotoxicity of ZnO NPs 
is statistically significant. TritonX-100 modified ZnO 
NPs, owing to its smaller size, should have instigated 
more cytotoxic effect [19] but a contradictory result was 
observed. One likely explanation for this effect is the 
coating of reaction site of ZnO NPs by biocompatible 
TritonX-100 which altered its cytotoxic property. This 
unexpected result provides strong foundation for the 
conclusion that the effect of surfactant is pronounced as 
synergy of its influence on two critical properties: size 
and surface modification rather than acting singularly 
on size and influencing cytotoxicity accordingly [20]. The 
different but comparable cytotoxic effects of ZnO NPs 
and modified ZnO NPs imputes that surface properties 
also plays important role in cytotoxicity of NPs along 
with its size.
No positive correlation was found between cytotoxicity 
and increasing concentration of stress at given concen-
tration range for NIH 3T3 (p = 0.0019 < 0.05). Although 
the effect of both NPs on NIH 3T3 is significantly less 
and pronounced in a concentration independent man-
ner from 12.5 to 100  µg/ml, effect of each particle on 
NIH 3T3 was found to be significant which was validated 
by results from two factor ANOVA between ZnO and 
modified ZnO NPs on NIH 3T3 up to 100  µg/ml that 
shows p value  >  0.05 for within group (concentration 
gradients) and p value  <  0.05 for between groups (ZnO 
Fig. 4 TEM images of modified ZnO at (a) 50 nm (b) 100 nm scale with histogram showing particle size distribution
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and modified ZnO NPs). Between concentration range 
25–100  µg/ml, percentage cell death after treatment 
with modified ZnO NPs in NIH 3T3 was less than that in 
treatment with unmodified NPs up to 20 %. This observa-
tion is on the agreement with the biocompatibility nature 
of TritonX [21].
Addressing above findings, it is evident that unmodi-
fied particles are more potent than modified particles on 
MDA-MB-231 but this potency also extends during its 
treatment in normal cell lines. This means that although 
the effect on cancer cell line may be greater in case of 
unmodified particles, effect on normal cell line is also 
greater. On the other hand, modified particles although 
prove to be less potent, their effect on normal cell line 
is even less. Since therapeutic significance of NPs can-
not be solely judged by its effect on cancer cell line, but 
rather should be analyzed through its comparative effect 
on normal and cancer cells, possible application of Tri-
tonX-100 modified ZnO NPs as therapeutic agent holds 
better promise than unmodified ZnO NPs.
Crystal violet staining and DNA fragmentation showing 
cytotoxicity on NPs treated cancer cells possibly via apoptosis
Apoptotic cells show distinct morphological and bio-
chemical hallmarks. Some of them include cell shrinkage, 
Fig. 5 FT-IR Spectra of (a) ZnO, (b) modified ZnO, (c) TritonX only 
and (d) Zinc Acetate Dihydrate from 350 to 4000 cm−1. Distinct 
peak of inorganic divalent metal oxide was seen below 500 cm−1 
in both ZnO and modified ZnO. Comparative peaks were observed 
between Triton X-100 only and modified ZnO. Peaks corresponding 
to 1200–1600 cm−1 are of symmetrical and asymmetrical stretching 
of C=O bond which were found significantly reduced in synthesized 
particle with respect to Zinc Acetate Precursor. Also, 3500 cm−1 
peak intensity for bonded −OH are significantly reduced conferring 
samples are of high purity
Fig. 6 Mean cell viability of (a) ZnO and (b) modified ZnO treatment on MDA-MB-231 and NIH 3T3. Both cells were treated with ZnO NPs at 
concentration gradient from 200 to 12.5 μg/mL for 24 h. Corresponding absorbance reading ofdissolved formazan was taken after its conversion 
by viable cells which was plotted with respect to control (untreated cells) against concentration gradient. Mean ± SE plot shows concentration 
dependent toxicity for MDA-MB-231 cell whereas no strong positive correlation was found in normal NIH 3T3 cell. Percent viability was also found 
relatively higher in case of normal NIH 3T3 than MDA-MB-231 at given concentration. Two factor ANOVA with α = 0.05 was performed for effective-
ness of ZnO NPs between two cell lines and p value for interaction was found to be less than 0.05 verifying difference in effectiveness of NPs on 
these two cell lines
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chromatin cleavage, nuclear condensation and disinte-
gration, formation of pyknotic bodies, etc. [22]. Crystal 
violet dye (Hexamethylpararosaniline) is a mixture of vio-
let rosanilins that stains nucleus dark blue and cytoplasm 
light blue. In solution, it dissociates into ions which upon 
entering the cell binds preferentially with negatively 
charged components, typically DNA where two adja-
cent A-T residues occur [23]. Since CV stains viable cells, 
reduction of viable cells in treated cells as seen in Fig. 8 in 
comparison to untreated cells verified the MTT result of 
cell cytotoxicity by NPs.
DNA fragmentation pattern is distinct in apoptotic 
cells creating laddering effect in contrast to necrotic 
cells in which random DNA fragmentation occur cre-
ating smear rather than ladder in gel [24]. Figure  9 
shows UV-illuminated gel of whole DNA extracted from 
treated and untreated cells with DNA ladder of 100 bp 
at rightmost position. Distinct bands of fragmented 
DNA can be observed in case of treated cells (both 
with ZnO and modified ZnO NPs). But no such band 
observed for untreated cells. This suggests that both 
modified and unmodified ZnO NPs induce DNA frag-
mentation within cells, supporting induction of apop-
tosis intracellularly [8, 25] and confirms that surface 




Zinc acetate dihydrate, sodium hydroxide and metha-
nol were purchased from Sigma Aldrich. ZnO NPs were 
synthesized using precipitation technique as described 
in [26]. 0.25  MNaOH was added to 0.05M zinc acetate 
containing 0.08  M TritonX-100 surfactant under vigor-
ous stirring at room temperature, the cloudy viscous 
sediment thus obtained was filtered using 42-grade fil-
ter paper under vacuum filtration, dried overnight at 
50 °Cand then calcinated at 200 °C for 2 h in muffle fur-
nace. In another setup, all above procedure was followed 
except no TritonX-100 was used.
Fig. 7 Cytotoxic effects of ZnO and modified ZnO on two cell lines. 
Non-linear dose response fit for MDA-MB-231 (Adj. R2 = 0.979) show-
ing strong correlation of cytotoxicity with increasing concentration. 
Plot for normal NIH 3T3 cell shows concentration independent effect 
of both particles below 100 µg/ml. Two factor ANOVA was used with 
α = 0.05 for comparing effects of both NPs on NIH-3T3 which gives 
p value of`0.001 < 0.05 signifying enhancement of selectivity by 
biocompatible polymer
Fig. 8 CV staining images of (a) Control (untreated) cells, (b) ZnO NPs treated cells and (c) modified ZnO NPs treated cells (MDA-MB-231) after 24 h 
treatment of stress. Cells were fixed by 4 % paraformaldehyde for 30 min, stained by 0.05 % Crystal violet for 30 min and then subsequently washed 
with distilled water followed by microscopic observation at 10X. This observation clearly shows less number of viable cells in treated cells than 
untreated control
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Characterization
XRD and TEM were carried out at IIT, Roorkee, India. 
X-ray diffraction spectra were recorded at 0.154  nm 
wavelength (λ) of Cu-kα radiation using Rigaku-Geiger 
diffractometer with range of 2θ from 5° to 80°. Phase 
identification and crystallographic planes were deter-
mined by comparing peak positions with reference 
JCPDS file. Particle size was computed using Scherrer’s 
equation: D = Kλ/βcosθ, where K = 0.9 is shape factor, β 
is FWHM in radians and θ is Bragg’s angle [27]. For TEM 
analysis, required volume of sample was sonicated in ace-
tone (1  %, w/v) and applied over carbon coated copper 
grid. TEM images were recorded at 10-KX magnification 
and 0.2-μm scale over JEOL 1011 (Tokyo, Japan) at 80 kV. 
Similarly, FT-IR spectroscopy was performed on powder 
samples and precursors using Shimadzu IR Prestige 21 
FT-IR Spectrometer and corresponding spectrum was 
generated using IR-Solution software.
Cell culture
Two cell lines; normal mouse fibroblast NIH 3T3 and 
human breast adenocarcinoma MDA-MB-231 were 
maintained at Kathmandu University while Dulbecco’s 
modified Eagle medium (DMEM; Life Technologies, 
USA), fetal bovine serum (Sigma, Germany), penicillin/
streptomycin (Sigma, Germany), MTT dye (Amresco, 
USA), Trypsin (Amresco, USA), and Amphotericin “B” 
(Sigma, Germany) were purchased. Cell lines were main-
tained in DMEM cell culture medium supplemented with 
10 % FBS, 0.5 % antibiotic solution (penicillin and strep-
tomycin stabilized with glutamine), 0.5  % antimycotic 
solution (amphotericin “B”) at 37  °C supplemented with 
5 % CO2 [28]. Stock solutions of both ZnO NPs (with and 
without TritonX-100) were prepared in Dulbecco’s phos-
phate buffer saline (pH 7.4 ± 0.1). These solutions were 
then sonicated in water bath sonicator (40 min) prior to 
use to prevent particle aggregation.
Cell viability assay
MTT assay as mentioned by [28] was performed. Log 
phase cells were harvested and seeded in 96 well plates at 
density of 10,000 cells per well. After 24 h of attachment, 
the media was replaced with fresh media supplemented 
with NPs at concentration range from 200 to 1.5625 µg/
ml via serial dilution. After 24 h of treatment, cells were 
washed with DPBS twice and 10 µl of 5 mg/mL MTT dye 
was added. It was incubated for 4 h and reading was taken 
at 570 nm with background subtraction of 630 nm band 
pass filter. Percent cell viability was expressed as percent 
relative absorbance of sample with respect to control and 
percentage death as percent relative difference.
CV staining
Cultured cells were seeded in 12 wells plate at density 
of 80,000 cells per well and incubated. After 24  h, cells 
were treated with NPs at 40 µg/ml for ZnO and 55 µg/ml 
for modified ZnO for another 24  h. Non-adherent cells 
were washed off using DPBS and remaining cells were 
fixed with 4 % paraformaldehyde for 30 min. Then 0.05 % 
of crystal violet solution in 20 % ethanol was added and 
left to stain for 30 min. Finally, excess stain was washed 
off using distilled water and observed on phase contrast 
microscope at 10X magnifications.
DNA fragmentation assay
Apoptotic DNA ladder kit was purchased from Invitro-
gen (Ref. KHO1021). MDA-MB-231 cells maintained in 
T25 flask were trypsinized and seeded in 6 wells plate at 
density of 80,000 cells per well. After 24 h, ZnO NPs were 
added at same concentrations mentioned in CV-staining. 
After another 24 h of treatment, media containing dead 
non-adhered cells were directly collected in falcon tube 
whereas adhered cells were trypsinized and collected. 
Thus obtained solutions were centrifuged at 1000 rpm for 
5 min and clear cell pellets were obtained with repeated 
washing and centrifuging with DPBS. DNA was then 
isolated using purchased kit protocol. 30  μl of each 
extracted DNA sample was loaded onto a 1.2 % Agarose 
Fig. 9 UV-Illumination of fragmented DNA bands of ZnO NPs and 
modified ZnO NPs treated cells in 1.2 % Agarose gel along with 
control untreated cells (leftmost) and 100 bps ladder (rightmost) 
segregated on 5 V/cm for 2 h
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gel containing 0.5 μg/ml EtBr. The gel was run at 30 Volts 
for 2  h and EtBr-stained DNA was visualized by trans-
illumination with UV light and photographed.
Statistical analysis
All statistical analyses were done at level of significance 
0.05. Dose-response curve was fitted under inbuilt func-
tion for dose-response in Origin8 Pro software using 
non-linear curve fitting model. Two-factor ANOVA 
for studying variance between and within samples was 
applied using Microsoft Excel 2010.
Conclusions
Easy and controlled synthesis of ZnO NPs posing pref-
erential cytotoxic property can be achievedat less than 
20 nm size using simple precipitation techniques with no 
impurities. Comparable morphology and crystallinity of 
nanoparticles was achieved by in  situ use of surfactant. 
Our results showed that use of surfactant decreased 
particle size possibly by coating surface and providing 
steric hindrances during particle growth but at the same 
time made surface more biocompatible thereby provid-
ing antagonistic effect between size and surface prop-
erty on toxicity. This can be observed in dose response 
curve of ZnO and modified ZnO on MDA-MB-231 
where modified ZnO has more EC50 values of 55.24 µg/
ml than unmodified, 38.44  µg/ml making it less potent. 
While there was concentration dependent cytotoxicity 
of NPs on cancer cell, no positive correlation was found 
between normal cell cytotoxicity and increasing concen-
tration of stress up to 100  µg/ml. Our research directs 
that ZnO NPs shows effective preferential cytotoxicity at 
a concentration range of 25 to 100 μg/mL with enhanced 
preferential cytotoxicity shown by the modification of 
TritonX-100. Distinct fragmented band observed in 
DNA fragmentation assay signifies that the mechanism 
of cytotoxicity on cancer cell is apoptosis. This result 
of enhanced preferential cytotoxicity by biocompatible 
polymer modified NPs can be exploited to make efficient 
anticancer agent comparing toxicity on both cancerous 
cell and normal proliferating cells.
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